Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01772745
Other study ID # mütf3
Secondary ID
Status Completed
Phase N/A
First received January 16, 2013
Last updated January 17, 2013
Start date January 2010
Est. completion date January 2013

Study information

Verified date January 2013
Source Maltepe University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

Laparoscopic techniques have allowed surgeons to perform complicated intrabdominal surgery with minimal trauma. Laparoscopic cholecystectomy has been recognized since 1987 as the gold standard procedure for gallbladder surgery. Single incision laparoscopic surgery (SILS) was developed with the aim of reducing the invasiveness of conventional laparoscopy. In this study we aimed to compare results of SILS cholecystectomy and three port conventional laparoscopic (TPCL) cholecystectomy prospectively


Description:

Single-incision laparoscopic procedures have evolved gradually to include a multitude of various surgeries. The current literature documents the use of a single-incision or single-port access surgery for cholecystectomies, adrenalectomies, splenectomies, appendectomies, herniorrhaphies, bariatrics, and colon surgery.

Total of 100 patients who undergoing laparoscopic cholecystectomy for gallbladder disorders will randomly assign to undergo SILS cholecystectomy group (n = 50) or TPCL cholecystectomy group (n= 50) according to a computer-generated table of random numbers. Demographics (ie, age, gender, body mass index (BMI), American Society of Anesthesiology (ASA) score, indication for operation, need for conversion to a standard or three port laparoscopic cholecystectomy, need for conversion to an open cholecystectomy will be recorded. Outcome measures include operative morbidity, operative time, pain score, hospital stay. Morbidity will be evaluated by rates of bile leak, wound infection, hospital readmission, and hernia.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Required laparoscopic cholecystectomy for gallbladder disease.

Exclusion Criteria:

- American Society of Anesthesiologists score (ASA) more than III,

- Patients had prior abdominal surgery,

- Patients admitted outside working hours with acute cholecystitis,

- Patients have choledocolithiasis,

- pregnancy,

- ongoing peritoneal dialysis,

- lack of written informed consent.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
SILS cholecystectomy
Single incision laparoscopic cholecystectomy will be performed
TPCL cholecystectomy
Three port laparoscopic cholecystectomy will br performed

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Maltepe University

Outcome

Type Measure Description Time frame Safety issue
Other Length of hospital stay Length of hospital stay will be recorded postoperative period. Average of 2 days No
Other Postoperative complications Postoperative complications will be recorded postoperative follow up.
Bleeding
Bile leakage
Intrabdominal injury
Wound infection
Port site hernia
24th hour, 2nd day, 3rd day, 7th day, 1st month, 3rd month, 6th month, 1st year Yes
Primary pain score Postoperative pain will be assessed according Visual analog scale from 0 (no pain) to 10 (worst pain imaginable. Postoperative six hour VAS (POSH-VAS) and postoperative first day VAS (POFD-VAS) will be recorded and compared. Postoperative first 24 hours No
Primary Intraoperative complications Per operative complications will be recorded.
Bleeding
Gallbladder perforation
Bile leakage
Bowel perforation
Complications associated with increased intra-abdominal pressure
Average of 70 minutes Yes
Secondary Operating time The operating time will be defined as the time from the first incision to the last suture's placement. Average of 70 minutes No
See also
  Status Clinical Trial Phase
Completed NCT01728584 - A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982) Phase 4
Completed NCT01938040 - Effect IV Ibuprofen and Inflammatory Responses Phase 4
Completed NCT00961506 - Prospective Evaluation of Laparoendoscopic Single Site Versus Laparoscopic Cholecystectomy Phase 2
Completed NCT01410734 - Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively) N/A
Withdrawn NCT00240123 - Effect of Benadryl Sedation During ERCP or EUS Phase 1
Completed NCT05745077 - Using Data to Achieve Surgical Health Equity in the Community N/A
Completed NCT00609726 - Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography N/A
Completed NCT01571479 - The Feasibility and Safety of a Three-Port Laparoscopic Cholecystectomy Using a 2-mm Mini-Instrument N/A
Completed NCT00889928 - A Trial to Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic Assistance N/A
Completed NCT00832767 - SILS™ Port Laparoscopic Cholecystectomy Post Market Study N/A